Oncorus

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oncorus and other ETFs, options, and stocks.

About ONCR

Oncorus, Inc. engages in the research and development of viral immunotherapies platform. It develops immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. 

CEO
Theodore T. Ashburn
CEOTheodore T. Ashburn
Employees
82
Employees82
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
82
Employees82

ONCR Key Statistics

Market cap
22.60M
Market cap22.60M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
70.34K
Average volume70.34K
High today
$0.94
High today$0.94
Low today
$0.8501
Low today$0.8501
Open price
$0.8704
Open price$0.8704
Volume
11.62K
Volume11.62K
52 Week high
$11.81
52 Week high$11.81
52 Week low
$0.7786
52 Week low$0.7786

ONCR Earnings

-$0.77
-$0.51
-$0.26
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, Pre-Market
ActualExpected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.